Letrozole-Femara is a type of hormone therapy drug to treat breast cancer in women who have had their menopause. Letrozole-Femara works by blocking up an enzyme called aromatase which in turn reduces the oestrogen quantity inside the body.
Letrozole-Femara is also known as aromatase inhibitor. Some of the other aromatase inhibitors available on the market include include Arimidex (anastrozole) and Aromasin (exemestane). The United States Food and Drug Administration (FDA) has approved Letrozole-Femara for treating local and metastatic breast cancer.
The fertility doctors have been using Letrozole-Femara for ovulation induction since 2001. A Canadian study presented at the American Society of Reproductive Medicine 2005 Conference proposes that it may raise the chances of birth defects compared with a control group. But a more elaborated review discovered no basis for worry when Letrozole-Femara is used for ovulation induction.
Letrozole-Femara shrinks estrogen levels by 98% while lifting up testosterone levels. This soaring percentage point permits jocks and musclemen to use Letrozole-Femara during or after a steroid cycle to annihilate the gynecomastia...